Using immunotherapy can reduce risk of returning skin cancer - Study

A new study shows using an immunotherapy can significantly reduce the risk of a patient's skin cancer returning.

Nearly two thirds of of patients treated with nivolumab at an earlier stage alongside surgery, experienced recurrence-free survival.

Anne Gribben from Dublin was diagnosed with stage three malignant melanoma in 2006 and is still cancer-free as a result of the treatment.

She was given one of two drug treatment options and says her health has been great since.

She said: "The results have been good because everything has been clear since and I started that in 2015."

- Digital Desk